Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.

Podobne zapisy

• The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
  od: Pitsavos, C, i wsp.
  Wydane: (2009)
• Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia
  od: Toutouzas, K, i wsp.
  Wydane: (2017)
• Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
  od: Charakida, M, i wsp.
  Wydane: (2009)
• Homocysteine: a risk factor for coronary artery disease?
  od: Marinou, K, i wsp.
  Wydane: (2005)
• Nitric oxide in coronary artery disease: Effects of antioxidants
  od: Tousoulis, D, i wsp.
  Wydane: (2006)